Herbert M. Stein
Chief Executive Officer at Apogee Technology, Inc.
Profile
Herbert M.
Stein is currently the President, CEO, CFO, Secretary & Director at Apogee Technology, Inc. He previously served as the Chairman & Chief Executive Officer at Organogenesis, Inc. from 1987 to 1999.
Herbert M. Stein active positions
Companies | Position | Start |
---|---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Chief Executive Officer | - |
Former positions of Herbert M. Stein
Companies | Position | End |
---|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Chief Executive Officer | 1998-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Health Technology |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
- Stock Market
- Insiders
- Herbert M. Stein